KZA 0.00% 8.0¢ kazia therapeutics limited

RPDD - priorty review vouchers

  1. 1,540 Posts.
    lightbulb Created with Sketch. 510
    I see a few posters seem to think KZA has already been awarded 2 PRVs which the company could sell any time now.

    That is incorrect. We have 2 RPD designations for PAX. We only get a voucher if PAX is FIRST approved in the indication. So still years away yet.

    We currently have no PRVs.

    We will never receive more than 1 PRV for PAX, we just have 2 separate opportunities.

    Given that GBM will likely be our first disease indication submitted for FDA approval making PAX ineligible for PRV, it is unlikely we will never get a PRV for PAX.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.